http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0304941-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
filingDate 1988-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1994-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_236a3845812c6cdaf0fd77be2f2a24b3
publicationDate 1994-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0304941-B1
titleOfInvention Pharmaceutically useful polymorphic modification of buspirone
abstract The invention relates to the lower melting polymorphic crystalline form of buspirone hydrochloride which has a melting point of about 188 DEG C. It is useful for treating anxiety in a patient in need of such treatment.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7649008-B2
priorityDate 1987-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406583
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2477
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129083571
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36431
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426513

Total number of triples: 26.